During the past decade, Swedish Neuroscience Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Swedish Neuroscience Research" are "Parkinson Disease" (2 trials), "Dementia With Lewy Bodies" (1 trials), "Giant Cell Glioblastoma" (1 trials), "Glioblastoma" (1 trials) and "Glioblastoma With Oligodendroglial Component" (1 trials). Many other conditions were trialed in "Swedish Neuroscience Research" in a lesser frequency.

Most popular intervention types in "Swedish Neuroscience Research" are "Drug" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "APL-130277" (1 trials), "Bevacizumab" (1 trials), "KLH" (1 trials), "Rindopepimut (CDX-110) with GM-CSF" (1 trials) and "Skin Biopsy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Swedish Neuroscience Research" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Swedish Neuroscience Research". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Swedish Neuroscience Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Swedish Neuroscience Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".